Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $136.62 USD
Change Today -1.59 / -1.15%
Volume 455.0K
HSIC On Other Exchanges
As of 5:20 PM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

henry schein inc (HSIC) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/29/15 - $149.95
52 Week Low
10/16/14 - $109.34
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HENRY SCHEIN INC (HSIC)

Related News

No related news articles were found.

henry schein inc (HSIC) Related Businessweek News

View More BusinessWeek News

henry schein inc (HSIC) Details

Henry Schein, Inc. provides health care products and services worldwide. It operates in two segments, Health Care Distribution; and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, such as infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, equipment repair, and high-tech and digital restoration equipment. This segment also provides animal health products consisting of branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services and products, including practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions comprising financial services on a non-recourse basis, e-services, practice technology, network and hardware services, and continuing education services for practitioners. The company primarily serves dental practitioners and laboratories, physician practices, and animal health clinics, as well as government, institutional health care clinics, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

18,000 Employees
Last Reported Date: 07/29/15
Founded in 1932

henry schein inc (HSIC) Top Compensated Officers

Executive Chairman and Chief Executive Office...
Total Annual Compensation: $1.3M
President, Chief Operating Officer, Executive...
Total Annual Compensation: $761.4K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $581.2K
Chief Administrative Officer, Executive Vice ...
Total Annual Compensation: $596.2K
Chief Strategic Officer, Executive Vice Presi...
Total Annual Compensation: $571.2K
Compensation as of Fiscal Year 2014.

henry schein inc (HSIC) Key Developments

Henry Schein Mulls Acquisitions

Henry Schein, Inc. (NasdaqGS:HSIC) is seeking acquisitions. Steve Paladino, Executive Vice President, Chief Financial Officer and member of the Board of Directors of Henry Schein, said, “We think that we can continue to expand our footprint and for us doing an acquisition that gives us a platform in a new market is much more advantageous than starting a de novo business.”

Lawsuits Filed Against Henry Schein by Gerard Fox Law P.C

Henry Schein, Inc. was hit with a series of lawsuits filed by Gerard Fox Law P.C. alleging the dental supply company is jeopardizing the public’s health, trust and the integrity of water supply through deceptive and underhanded business practices. The three complaints allege that the company and its top executives maliciously misrepresented their intentions when they induced former business partner Ken Rosenblood to bring them into a deal to buy two health compliance companies with which they were actually competing; not to grow them, not to improve compliance, but to bury them in order to protect their existing profit centers that put patient health and safety at needless risk. Rosenblood, through his companies, committed himself to making infection control compliance easy for dentists and their practices safe for patients. These lawsuits allege that Henry Schein wanted nothing to do with improved safety and compliance solutions because they disrupt and threaten the profits of its existing business model. The complaints allege that Ken Rosenblood discovered, after joining forces with Henry Schein, Inc., that Henry Schein’s business interests are often completely opposed to the product lines they purchased with Rosenblood and that were developed by Rosenblood. The complaints allege Henry Schein did not want to expose their customers to Ken Rosenblood’s cutting edge compliance technology, because Schein offered competing products of lower quality that they were more interested in selling. The complaints allege that Schein would not put Rosenblood’s innovative products in their catalogue because they conflict with its other purposes.

Henry Schein Announces Executive Changes

Henry Schein, Inc. announced the completion of its 85% investment in Jorgen Kruuse A/S (KRUUSE). The transaction was announced on June 23, 2015. Jesper Smith, who has served as Chief Executive Officer of KRUUSE since 2009, joins Henry Schein with continuing responsibility for the KRUUSE business. Other members of the KRUUSE leadership team will also remain with the company, including Peter Eriksen Jensen, who will serve as Vice Chairman of the KRUUSE Board of Directors, and Mads Kruuse, who will serve as a member of the KRUUSE Board.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSIC:US $136.62 USD -1.59

HSIC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CDW Corp/DE $41.83 USD +0.06
Cintas Corp $85.74 USD -1.86
Hologic Inc $37.47 USD -1.31
Tractor Supply Co $86.57 USD -1.84
Waters Corp $117.38 USD -2.36
View Industry Companies

Industry Analysis


Industry Average

Valuation HSIC Industry Range
Price/Earnings 25.0x
Price/Sales 1.1x
Price/Book 4.0x
Price/Cash Flow 24.6x
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENRY SCHEIN INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at